Top compounds associated with response to CLDN34


Feature Type Standardized
Nominal ANOVA
mRNA PX-12 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA azacitidine CTRPv2 pan-cancer AAC -0.017 0.7
mRNA I-BET151 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.7
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.016 0.7
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.014 0.7
mRNA CD-1530 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA masitinib CTRPv2 pan-cancer AAC 0.015 0.7
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV